Search for: "Johnson, N. v. Page, D."
Results 81 - 100
of 168
Sorted by Relevance
|
Sort by Date
25 Dec 2018, 3:00 am
P. 38.1(d). [read post]
18 Feb 2012, 5:15 am
” P. 30, n. 15. [read post]
28 Jun 2007, 10:16 am
We'd expect nothing less.The first fascinating issue is the plaintiffs' purported "damages. [read post]
3 Feb 2011, 2:11 pm
App. 1978), aff’d, 402 N.E.2d 194 (Ill. 1980) (not recognized in Illinois); Miller v. [read post]
1 Feb 2013, 9:42 am
See Demahy v. [read post]
13 Oct 2008, 12:12 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Senators Specter and Leahy express concern about ACTA Treaty (Techdirt) (Intellectual Property Watch) (IP Justice) (Michael Geist) (Public Knowledge) (Intellectual Property Watch) Commerce Department cites questionable stats, Chamber of Commerce uses them to ask Bush to sign PRO IP Bill into law (Techdirt) (Techdirt) (Public… [read post]
26 Mar 2009, 6:48 am
In an exhaustive 112-page opinion, U.S. [read post]
22 Jan 2021, 7:53 am
I'd rather just have continued to watch cases like Epic Games v. [read post]
11 Apr 2011, 4:19 am
Johnson & Johnson, et. al. [read post]
19 Sep 2008, 6:00 pm
: (IP finance), United States: An open letter for the General Counsel of the PTO on your San Diego presentation next week: (Hal Wegner), United States: Cocoa genome: breaking intellectual property barriers: (Thomson Reuters Scientific), Vietnam: Patentability of second medical use claims in Vietnam is again questionable: (Trung Truc JSC) Pharma & Biotech - Products Allegra (Fexofenadine) - Canada: Motion for summary judgment of noninfringement dismissed in patent infringement… [read post]
18 Oct 2010, 3:07 am
(Docket Report) District Court N D Illinois: Loosely related state law claims sufficient for supplemental jurisdiction: Von Holdt v. [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore… [read post]
18 Apr 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Ranbaxy and AstraZeneca reach agreement in Esomeprazole patent litigation: (SmartBrief), (IPBiz), (Spicy IP), (Profitability through Simplicity), (IP Law360), (Philip Brooks), (GenericsWeb), Cadbury loses Australian battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks… [read post]
4 Aug 2017, 3:26 am
Department of Justice in the Zarda v. [read post]
6 Oct 2017, 11:39 pm
Those pages are often not attached to the archived Signature Page, but the program lender’s home state can generally be inferred from the identity of the lender as shown both on the Signature Page and on the Note Disclosure Statement. [read post]
23 Feb 2011, 6:07 am
Slip op. at 10 n.41. [read post]
9 Nov 2014, 6:46 pm
Johnson, 682 F.Supp. 1033 (W.D.Mo.1988).I.BackgroundFor almost a century, the Federal Government employed in criminal cases a system of indeterminate sentencing. [read post]
2 Feb 2015, 2:56 pm
Edgar Hoover, Lyndon Johnson, and others. [read post]
31 Aug 2007, 11:08 am
Johnson v. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
